Inherent

Founded in 2025 by co-founders Louis Kirsch and Kaloyan Aleksiev in London, UK, Inherent specializes in creating AI systems that support scientific research. In May 2026, Inherent raised USD 50 million in seed funding led by investor Index Ventures, and Radical Ventures with participation from another investor NVentures (NVIDIA's venture capital arm), Ex/Ante, Metaplanet, Macroscopic Ventures, Mythos Ventures. As of July 2026, the company is led by CEO Tantum Collins. Inherent is at the forefront of revolutionizing scientific research by developing general-purpose inventive AI systems aimed at enhancing research capabilities across various domains.

Their core offerings focus on creating AI agents that augment creativity, accelerate innovation, and foster collaboration among R&D teams. These AI peers are designed to not only address well-defined questions but also to help researchers identify which inquiries to pursue, thereby promoting an open-ended exploration of scientific knowledge. Inherent's technological solutions are targeted at global markets, with particular focus on industries such as pharmaceuticals, biotechnology, and advanced materials, where the need for innovative research methodologies is paramount. Their products are tailored to empower institutions to undertake high-throughput and low-latency experimentation, thereby facilitating a transformative approach in scientific inquiry.

Inherent generates revenue through a structured model that emphasizes B2B partnerships and collaborations with research institutions and corporations. Their transactional framework involves subscription services for access to their AI systems, providing ongoing support and updates as part of a comprehensive research tool suite. Flagship products include generative design tools that optimize the research and development process, enabling clients to enhance their operational efficiency. Revenue realization may occur through annual licensing fees or project-based agreements, where clients pay for specific services that leverage Inherent's AI technologies for scientific advancement.

This structured approach allows for recurring revenue streams and positions Inherent as an essential partner in the evolving landscape of AI-driven research. Inherent plans to utilize the USD 50. 00 mn raised in Seed funding to develop its Faraday AI platform, expand research and engineering efforts, and grow its team. The company aims to launch new product offerings that will enhance its AI capabilities and is looking to expand into additional global markets, particularly in the pharmaceuticals and biotechnology sectors, by the end of 2027.